These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 17526808

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J, Yip-Schneider M, Albertin F, Wiesenauer C, Wang Y, Schmidt CM.
    J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
    Manov I, Pollak Y, Broneshter R, Iancu TC.
    FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
    [Abstract] [Full Text] [Related]

  • 4. Involvement of the multidrug resistance P-glycoprotein in acetaminophen-induced toxicity in hepatoma-derived HepG2 and Hep3B cells.
    Manov I, Bashenko Y, Hirsh M, Iancu TC.
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):213-24. PubMed ID: 16930294
    [Abstract] [Full Text] [Related]

  • 5. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.
    Liang G, Tang A, Lin X, Li L, Zhang S, Huang Z, Tang H, Li QQ.
    Int J Oncol; 2010 Jul; 37(1):111-23. PubMed ID: 20514403
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
    Ding SZ, Smith MF, Goldberg JB.
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin II activates p44/42 MAP kinase partly through PKCepsilon in H295R cells.
    Lehoux JG, Lefebvre A.
    Mol Cell Endocrinol; 2007 Feb; 265-266():121-5. PubMed ID: 17215072
    [Abstract] [Full Text] [Related]

  • 11. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
    Meijering BD, van der Wouden EA, Pelgröm V, Henning RH, Sharma K, Deelman LE.
    J Vasc Res; 2009 May; 46(5):459-68. PubMed ID: 19204403
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells.
    Qian F, Wei D, Zhang Q, Yang S.
    Biomed Pharmacother; 2005 Apr; 59(3):64-9. PubMed ID: 15795098
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines.
    Wang J, Chan JY, Fong CC, Tzang CH, Fung KP, Yang M.
    Liver Int; 2009 Oct; 29(9):1338-47. PubMed ID: 19627484
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
    Kubo T, Shimose S, Matsuo T, Sakai A, Ochi M.
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):111-6. PubMed ID: 17874104
    [Abstract] [Full Text] [Related]

  • 19. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
    Shen J, Zhang W, Wu J, Zhu Y.
    Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.